DOI QR코드

DOI QR Code

Effects of Herbal Remedy for Diabetes Mellitus-01 (HRDM-01) on Liver and Serum Lipid Level in Diabetic Rats

당뇨한약복합처방(Herbal Remedy for Diabetes Mellitus-01, HRDM-01)이 당뇨병성 흰쥐의 간 및 혈중 지질에 미치는 영향

  • Kim, Hyung-Woo (School of Korean medicine, Pusan National University) ;
  • Ha, Tae-Hoon (Department of Oriental medicine, Graduated school of Dongeui University) ;
  • Cho, Myung-Rae (College of Oriental medicine, Dongshin University) ;
  • Cho, Su-In (School of Korean medicine, Pusan National University)
  • 김형우 (부산대학교 한의학전문대학원) ;
  • 하태훈 (동의대학교 일반대학원 한의학과) ;
  • 조명래 (동신대학교 한의과대학) ;
  • 조수인 (부산대학교 한의학전문대학원)
  • Received : 2010.08.13
  • Accepted : 2010.09.13
  • Published : 2010.09.30

Abstract

Objective:The Herbal Remedy for Diabetes Mellitus-01 (HRDM-01) is composed of 11 species of medicinal plants. HRDM-01 is used as anti-hyperglycaemic agent. Anti-hyperglycaemic agents in western medicine often have hepatotoxicities. Therefore, we investigated safety of HRDM-01, especially in liver functions. Methods:We investigated the effects of HRDM-01 on liver function measuring serum AST, ALT and LDH levels and histopathological changes of liver tissue using photomicroscope. In addition, we also investigated the effects on serum lipid levels such as total cholesterol, HDL-cholesterol and triglyceride. Results:In our experiment, single injection of streptozotocin elevated levels of AST and ALT in serum. But LDH level was not affected. In addition, our animal model showed elevated levels of total cholesterol and triglyceride in serum. 30 days treatment with HRDM-01 lowered serum AST level. Serum levels of ALT and LDH did not affected. In addition, HRDM-01 lowered serum triglyceride level significantly. In histopathological observation, we did not find any abnormal changes in all experimental groups. Conclusions:Briefly, HRDM-01 did not elevate serum levels of ALT, LDH, total cholesterol and did not affect histopathological changes in liver tissues. Moreover, HRDM-01 lowered serum AST, triglyceride, which are elevated by induction of diabetes mellitus. These results suggest the safety of HRDM-01 in diabetic treatment.

Keywords

References

  1. Angulo P. Nonalcoholic Fatty Liver Disease. N Engl J Med 2002;346:1221-1231. https://doi.org/10.1056/NEJMra011775
  2. 김재택. 당뇨병과 간기능 이상;당뇨병환자에서 간효소치 상승의 기전. 임상당뇨병. 2006;7(2):120-123.
  3. Shimomura I, Matsuda M, Hammer RE, et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ab/ab mice. Mol Cell 2000;6:77-86. https://doi.org/10.1016/S1097-2765(05)00010-9
  4. 이기영. 당뇨병과 간기능 이상;간기능 이상 당뇨병환자에서 약물사용/경구혈당강하제, 스타틴. 임상당뇨병. 2006;7(2):130-138.
  5. 이은방, 조명래, 김재홍, 류충열. 한약복합처방의 경구투여가 Streptozotocin에 의해 유발된 당뇨병 백서의 혈당과 항산화효소계에 미치는 영향. 대한침구학회지. 2008;25(1):57-72.
  6. Crowley LV: The Reitman-Frankel colorimetric transaminase procedure in suspected myocardial infarction. Clin Chem. 1967;13(6):482-487.
  7. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J. 1991;278: 609-619. https://doi.org/10.1042/bj2780609
  8. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance:a metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000. https://doi.org/10.1002/hep.20920
  9. Defronzo RA, Goodman AM. The multicenter metformin study group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:541-549. https://doi.org/10.1056/NEJM199508313330902
  10. Perriello G, Misericordia P. Volpi E, Santucci A, Ferrannini E, et al. Acute anti-hyperglycemic mechanism of metformin in NIDDM:Evience for suppression of lipid oxidation and hepatic glucose production. Diabetes. 1994;43:920-928. https://doi.org/10.2337/diabetes.43.7.920
  11. Kurt J. Isselbacher, Eugene Braunwald, Jean D. Wilson, Joseph B. Martin, Anthony S. Fauci, Dennis L. Kasper. Harrison's principles of internal medicine. Seoul:Jung Dam Publishing Co. 1997;2:1553-1555.
  12. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis:epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-5281. https://doi.org/10.1001/jama.287.19.2570
  13. 원규장. 당뇨병과 심혈관질환:당뇨병환자에서 심혈관질 환의 위험요소. 임상당뇨병. 2008;9(1):27-29.